Advaxis, Inc.

Home » Advaxis, Inc.

Secondary

Advaxis, Inc.

Advaxis, Inc. is a late-stage biotechnology company focused on the discovery, development and commercialization of proprietary Lm-based antigen delivery products.

Symbol

ADXS

Last Closing Price
$2.51

Shares
10,000,000

Effective Date
February 22, 2018

Underwriters
Jefferies, Guggenheim Securities

To view the prospectus for Advaxis, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253